| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 1124 | 13 | 678 | 83 | 1011 | 172 | 1047 |
| ERLYTX | 74 | 1 | 52 | 7 | 85 | 9 | 55 |
| GI | 168 | 3 | 157 | 19 | 231 | 34 | 207 |
| GU | 414 | 13 | 678 | 58 | 706 | 98 | 597 |
| LEUK | 167 | 6 | 313 | 20 | 244 | 34 | 207 |
| LUNG | 211 | 3 | 157 | 18 | 219 | 31 | 189 |
| LYMPH | 426 | 7 | 365 | 32 | 390 | 65 | 396 |
| MELAN | 8 | 0 | 0 | 0 | 0 | 1 | 6 |
| MMYEL | 112 | 0 | 0 | 7 | 85 | 22 | 134 |
| MULT | 48 | 2 | 104 | 3 | 37 | 5 | 30 |
| OTHER | 44 | 0 | 0 | 1 | 12 | 2 | 12 |
| Total | 2796 | 48 | 2504 | 248 | 3020 | 473 | 2880 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 215 | 4 | 209 | 18 | 219 | 35 | 213 |
| ERLYTX | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| GI | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| GU | 6 | 0 | 0 | 1 | 12 | 3 | 18 |
| LEUK | 615 | 9 | 470 | 48 | 584 | 103 | 627 |
| LUNG | 367 | 1 | 52 | 28 | 341 | 65 | 396 |
| LYMPH | 1 | 0 | 0 | 1 | 12 | 1 | 6 |
| OTHER | 17 | 0 | 0 | 2 | 24 | 4 | 24 |
| PEOLC | 53 | 0 | 0 | 4 | 49 | 4 | 24 |
| PREV | 223 | 2 | 104 | 12 | 146 | 30 | 183 |
| SXQOL | 650 | 12 | 626 | 45 | 548 | 94 | 572 |
| Total | 2149 | 28 | 1461 | 159 | 1935 | 339 | 2063 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 1124 | 13 | 678 | 83 | 1011 | 172 | 1047 |
| CCD | 215 | 4 | 209 | 18 | 219 | 35 | 213 |
| ERLYTX | 75 | 1 | 52 | 7 | 85 | 9 | 55 |
| GI | 169 | 3 | 157 | 19 | 231 | 34 | 207 |
| GU | 420 | 13 | 678 | 59 | 718 | 101 | 615 |
| LEUK | 782 | 15 | 783 | 68 | 828 | 137 | 834 |
| LUNG | 578 | 4 | 209 | 46 | 560 | 96 | 584 |
| LYMPH | 427 | 7 | 365 | 33 | 402 | 66 | 402 |
| MELAN | 8 | 0 | 0 | 0 | 0 | 1 | 6 |
| MMYEL | 112 | 0 | 0 | 7 | 85 | 22 | 134 |
| MULT | 48 | 2 | 104 | 3 | 37 | 5 | 30 |
| OTHER | 61 | 0 | 0 | 3 | 37 | 6 | 37 |
| PEOLC | 53 | 0 | 0 | 4 | 49 | 4 | 24 |
| PREV | 223 | 2 | 104 | 12 | 146 | 30 | 183 |
| SXQOL | 650 | 12 | 626 | 45 | 548 | 94 | 572 |
| Total | 4945 | 76 | 3965 | 407 | 4956 | 812 | 4943 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 688 | 8 | 417 | 59 | 718 | 107 | 651 |
| ERLYTX | 55 | 1 | 52 | 7 | 85 | 9 | 55 |
| GI | 133 | 3 | 157 | 17 | 207 | 28 | 170 |
| GU | 304 | 8 | 417 | 42 | 511 | 68 | 414 |
| LEUK | 102 | 3 | 157 | 9 | 110 | 16 | 97 |
| LUNG | 137 | 2 | 104 | 13 | 158 | 21 | 128 |
| LYMPH | 279 | 3 | 157 | 19 | 231 | 40 | 244 |
| MELAN | 8 | 0 | 0 | 0 | 0 | 1 | 6 |
| MMYEL | 64 | 0 | 0 | 4 | 49 | 12 | 73 |
| MULT | 20 | 1 | 52 | 2 | 24 | 3 | 18 |
| OTHER | 44 | 0 | 0 | 1 | 12 | 2 | 12 |
| Total | 1834 | 29 | 1513 | 173 | 2105 | 307 | 1868 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 157 | 3 | 157 | 11 | 134 | 25 | 152 |
| ERLYTX | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| GI | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| GU | 6 | 0 | 0 | 1 | 12 | 3 | 18 |
| LEUK | 250 | 6 | 313 | 19 | 231 | 39 | 237 |
| LUNG | 224 | 0 | 0 | 22 | 268 | 46 | 280 |
| LYMPH | 1 | 0 | 0 | 1 | 12 | 1 | 6 |
| OTHER | 17 | 0 | 0 | 2 | 24 | 4 | 24 |
| PEOLC | 45 | 0 | 0 | 4 | 49 | 4 | 24 |
| PREV | 223 | 2 | 104 | 12 | 146 | 30 | 183 |
| SXQOL | 477 | 9 | 470 | 35 | 426 | 68 | 414 |
| Total | 1402 | 20 | 1044 | 107 | 1302 | 220 | 1338 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 884 | 13 | 678 | 75 | 913 | 146 | 889 |
| CCD | 165 | 3 | 157 | 11 | 134 | 21 | 128 |
| ERLYTX | 56 | 1 | 52 | 7 | 85 | 9 | 55 |
| GI | 143 | 2 | 104 | 15 | 183 | 29 | 177 |
| GU | 339 | 8 | 417 | 40 | 487 | 69 | 420 |
| LEUK | 355 | 9 | 470 | 28 | 341 | 55 | 335 |
| LUNG | 394 | 2 | 104 | 39 | 475 | 70 | 426 |
| LYMPH | 280 | 3 | 157 | 20 | 244 | 41 | 250 |
| MELAN | 8 | 0 | 0 | 0 | 0 | 1 | 6 |
| MMYEL | 64 | 0 | 0 | 4 | 49 | 12 | 73 |
| MULT | 41 | 0 | 0 | 0 | 0 | 5 | 30 |
| OTHER | 113 | 0 | 0 | 3 | 37 | 6 | 37 |
| PEOLC | 48 | 1 | 52 | 3 | 37 | 6 | 37 |
| PREV | 223 | 2 | 104 | 12 | 146 | 30 | 183 |
| SXQOL | 477 | 9 | 470 | 35 | 426 | 68 | 414 |
| Total | 3590 | 53 | 2765 | 292 | 3557 | 568 | 3460 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 978 | 10 | 522 | 77 | 937 | 161 | 980 |
| ERLYTX | 70 | 1 | 52 | 6 | 73 | 8 | 49 |
| GI | 98 | 2 | 104 | 10 | 122 | 21 | 128 |
| GU | 302 | 10 | 522 | 47 | 572 | 75 | 457 |
| LEUK | 137 | 5 | 261 | 17 | 207 | 30 | 183 |
| LUNG | 185 | 3 | 157 | 15 | 183 | 27 | 164 |
| LYMPH | 356 | 7 | 365 | 32 | 390 | 62 | 377 |
| MMYEL | 99 | 0 | 0 | 7 | 85 | 21 | 128 |
| MULT | 48 | 2 | 104 | 3 | 37 | 5 | 30 |
| Total | 2273 | 40 | 2087 | 214 | 2606 | 410 | 2496 |
| Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| Member | 1888 | 27 | 1409 | 167 | 2033 | 310 | 1887 |
| AFFIL | 123 | 0 | 0 | 6 | 73 | 8 | 49 |
| CCOP/NCORP | 1225 | 22 | 1148 | 107 | 1303 | 209 | 1272 |
| Non-SWOG | 1707 | 25 | 1304 | 125 | 1522 | 283 | 1723 |
| Total | 4943 | 74 | 3861 | 405 | 4931 | 810 | 4931 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| LUNG | S1900J | MET Amplification: Amivantamab Hyaluronidase | 1 | N | 15-OCT-26 |
| OTHER | NRGHN009 | HN, RT + HD Cisp vs RT + LD Cisp for SCCHN | 1 | E | 02-OCT-26 |
| ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
|---|---|---|---|---|
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 9 |
| SXQOL | S2013 | I-CHECKIT: ICI toxicity risk prediction study | 1 | 9 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 8 |
| BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 6 |
| GU | S2419 | Renal, adv clear cell, IO +/- Biotx, BIOFRONT | 1 | 5 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 2 | 4 |
| LYMPH | S2308 | FL, LTB, Mosunetuzumab vs Rituximab | 1 | 4 |
| GU | S2427 | Blad, MIBC, RT + Pembrolizumab | 1 | 4 |